Scientists at Oxford University may have developed a test that is more sensitive to diagnosing mesothelioma.
The researchers were seeking to find a method to distinguish mesothelioma as a cause of pleural effusion, the build-up of fluid in the pleural cavity surrounding the lungs. Pleural effusion has many causes, but more than 90% of people with mesothelioma have this symptom.
The study looked at levels of the protein mesothelin - which is released in high quantities in the pleural fluid of most patients with mesothelioma.
It was found that quantities of the protein were much greater in patients with mesothelioma than in those with secondary lung cancers, and 10 times higher than those with benign conditions.
It is hoped that this technique will allow doctors to diagnose mesothelioma at an earlier stage, using fewer invasive procedures. This will mean doctors can intervene at an earlier stage to treat the cancer, and claims for compensation for mesothelioma can be instigated earlier.
The study is due to be published in the American Journal of Respiratory and Critical Care Medicine at the start of September.
Contact us on freephone 0800 358 3848
Or start your claim online.
"The group is praised for its commitment to 'demystifying the legal process' while this is a firm for which the client has always been a priority"
Fieldfisher has successfully been recognised as an "Occupation and Asbestos Disease Specialists" Fieldfisher are now recognised as assessors
Charities we support
Asbestos rulings provide glimmer of hope for cancer sufferers
Employers can no longer hide behind a statistic that claimed to show a ‘safe’ level of exposure, which could pave the way for a wave of compensation claims, writes Peter Williams for The Times Brief.
Claimant lawyers hail landmark asbestos risk ruling
Caroline Pinfold's landmark case of Bussey vs Anglia Heating Ltd. was featured in the Law Society Gazette
Court of Appeal offers compensation hope to victims of asbestos poisoning
A landmark ruling that could pave the way for compensation for thousands of people suffering from cancer caused by asbestos.
BTOG Conference 2018
Fieldfisher attended the 2018 British Thoracic Oncology Group Conference held in January 2018.